Colin Hill - Jun 17, 2024 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Curt Oltmans as attorney-in-fact for Colin Hill
Stock symbol
FULC
Transactions as of
Jun 17, 2024
Transactions value $
$0
Form type
3
Date filed
6/18/2024, 04:10 PM
Previous filing
Dec 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FULC No securities are beneficially owned 0 Jun 17, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit Index: 24.1 Power of Attorney